Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
08/24/2011 | CN101204446B Soft capsule containing medicine for acute and chronic hepatitis |
08/24/2011 | CN101190288B Sustained-release oral traditional Chinese medicine preparation for treating gastric ulcer and preparation method thereof |
08/24/2011 | CN101015312B Health care functional tea for conditioning subhealthy state |
08/23/2011 | US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors |
08/23/2011 | US8003772 Chimeric PUFA polyketide synthase systems and uses thereof |
08/23/2011 | US8003615 Stable vitamin B6 derivative |
08/23/2011 | US8003347 Nucleic acids encoding ChemerinR ligands |
08/23/2011 | US8003131 Biomaterial derived from vertebrate liver tissue |
08/23/2011 | CA2594185C Solid dosage forms comprising a substituted benzimidazole derivative and a buffer |
08/23/2011 | CA2516333C Drug for reducing side effects in ribavirin / interferon combination therapy |
08/23/2011 | CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
08/23/2011 | CA2463690C Granules containing acid-unstable chemical in large amount |
08/23/2011 | CA2377209C Therapeutic peptide-based constructs |
08/18/2011 | WO2011100671A2 Methods and compositions to improve mechanical resistance of teeth |
08/18/2011 | WO2011099514A1 Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism |
08/18/2011 | WO2011099000A2 Pharmaceutical composition for treating the gastrointestinal tract |
08/18/2011 | WO2011098990A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases |
08/18/2011 | WO2011098938A1 Novel solvate of dexlansoprazole |
08/18/2011 | WO2011098579A1 Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention |
08/18/2011 | WO2011098568A1 Lactocepins for use in the treatment of ip-10-mediated inflammatory diseases |
08/18/2011 | WO2011097788A1 Use of pentoxifylline for preventing or treating constipation |
08/18/2011 | WO2011097688A1 Protein domains and uses therefor |
08/18/2011 | WO2010144865A9 Methods for treating gastrointestinal disorders |
08/18/2011 | US20110201691 Modulation of fibroblast activity |
08/18/2011 | US20110201685 Compositions |
08/18/2011 | US20110201680 formulation of silymarin with high efficacy and prolonged action and the preparation method thereof |
08/18/2011 | US20110201663 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists |
08/18/2011 | US20110201656 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
08/18/2011 | US20110201651 Mitotic kinesin inhibitors and methods of use thereof |
08/18/2011 | US20110201647 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase |
08/18/2011 | US20110201644 Crystalline form of a benzimidazole-carboxamide medicinal compound |
08/18/2011 | US20110201629 Cyclohexyl amide derivatives as crf receptor antagonists |
08/18/2011 | US20110201611 Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof |
08/18/2011 | US20110201608 Substituted naphthyridines and use thereof as medicines |
08/18/2011 | US20110201604 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof |
08/18/2011 | US20110201601 Inhibitors of the shiga toxins trafficking through the retrograde pathway |
08/18/2011 | US20110201590 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
08/18/2011 | US20110201589 New bradykinin b1 antagonists |
08/18/2011 | US20110201587 Hsp90 inhibitors and methods of use |
08/18/2011 | US20110201580 Pyrrolidine derivatives |
08/18/2011 | US20110201574 Fatty acid amide hydrolase inhibitors |
08/18/2011 | US20110201568 Phyotochemical composition and a process thereof |
08/18/2011 | US20110200680 Water insoluble polymer: starch-based film coatings for colon targeting |
08/18/2011 | US20110200677 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer |
08/18/2011 | US20110200668 Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics |
08/18/2011 | US20110200645 DHA Free Fatty Acid Emulsions |
08/18/2011 | US20110200644 DHA Ester Emulsions |
08/18/2011 | US20110200613 Use of B Cell Expansion Agents in Generating Antibodies |
08/18/2011 | US20110200611 Plasma kallikrein binding proteins |
08/18/2011 | US20110200610 Immuno-Modulating Compositions for the Treatment of Immune-Mediated Disorders |
08/18/2011 | US20110200600 Diagnosis and prognosis of immune disorders using stat4 expression |
08/18/2011 | US20110200587 Aminothiazolones as estrogen related receptor-alpha modulators |
08/18/2011 | US20110200586 Aminothiazolones as estrogen related receptor-alpha modulators |
08/18/2011 | US20110200570 Composition and Method for Treating Infections and Promoting Intestinal Health |
08/18/2011 | CA2789595A1 Methods and compositions to improve mechanical resistance of teeth |
08/18/2011 | CA2787727A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases |
08/17/2011 | EP2357200A1 Human antibodies that bind human TNFalpha |
08/17/2011 | EP2357193A1 Human GIL-19/AE289 proteins and polynucleotides encoding same |
08/17/2011 | EP2357175A1 isoquinoline derivatives AND THEIR USE IN INCREASING ENDOGENEOUS ERYTHROPOIETIN |
08/17/2011 | EP2357008A1 Albumin fusion proteins |
08/17/2011 | EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation |
08/17/2011 | EP2356995A2 Process of preparation of formulations of the peptide Angiotensin-(1-7) and its analogues, agonists and antagonists using cyclodextrins, liposomes and biodegradable polymers and/or mixtures and products thereof |
08/17/2011 | EP2356994A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
08/17/2011 | EP2356987A1 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
08/17/2011 | EP2356119A1 Peripheral opioid receptor antagonists and uses thereof |
08/17/2011 | EP2355848A2 Blockers of light, ltalpha1beta2 and ltalpha2beta1 or their receptor ltbetar for the prevention and treatment of chronic hepatitis and other liver diseases |
08/17/2011 | EP2355846A2 Immunogenic escherichia coli heat stable enterotoxin |
08/17/2011 | EP2355810A2 Methods for preventing or reducing carcinogenesis or oxidative stress |
08/17/2011 | EP2129216B1 Production of a viable, storable worm egg suspension |
08/17/2011 | EP2127668B1 Glycosyltransferase for treating Inflammatory Bowel Disease |
08/17/2011 | EP1725223B1 Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
08/17/2011 | EP1485360B1 Sodium channel blockers |
08/17/2011 | EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
08/17/2011 | EP1444233B1 A2b adenosine receptor antagonists |
08/17/2011 | EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
08/17/2011 | CN201928937U 桑叶除臭脱涩设备 Mulberry deodorant Deastringency equipment |
08/17/2011 | CN1899363B Chinese medicine composition for increasing immunity and its preparing method |
08/17/2011 | CN1895598B Chinese-medicinal powder for nourishing kidney of fowl |
08/17/2011 | CN1843426B Chinese medicine composition for treating acute and chronic gastroenteritis and preparing method thereof |
08/17/2011 | CN1715926B Use of neuregulin mutant |
08/17/2011 | CN1549717B Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, and pharmaceutical uses |
08/17/2011 | CN102159567A Process for the preparation of esomeprazole magnesium in a stable form |
08/17/2011 | CN102159233A Treatment of inflammatory bowel diseases with mammal beta defensins |
08/17/2011 | CN102159224A Pro biotic foodstuff and/or drinking water adjunct and use thereof |
08/17/2011 | CN102159222A Bioactive agent,pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent |
08/17/2011 | CN102153613A Method for preparing prunellin and application |
08/17/2011 | CN102153540A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
08/17/2011 | CN102153538A Benzocyclodirivative |
08/17/2011 | CN102153492A Treatment medicament for resisting infectious diseases, and preparation method and application thereof |
08/17/2011 | CN102151547A Method for controlling adsorption, storage and release of guest molecules by using mesoporous material |
08/17/2011 | CN102151328A Content detection method of traditional Chinese medicine preparation solid-intestine capsule for treating chronic diarrhea |
08/17/2011 | CN102151319A Hepatitis treatment medicament for oral administration |
08/17/2011 | CN102151304A Gastric stasis system of total alkaloids of coptis and evodia rutaecarpa as well as preparation method and application thereof |
08/17/2011 | CN102151302A Rhubarb liposome for external use, and preparation method and application thereof |
08/17/2011 | CN102151298A Externally applied preparation for relieving pain and diminishing inflammation, preparation method and detection method thereof |
08/17/2011 | CN102151286A Hydrotalcite tablet and preparation method thereof |
08/17/2011 | CN102151282A Application of iridoid glycoside and derivatives thereof as plasmin inhibitor and medicine composites of plasmin inhibitor |
08/17/2011 | CN102151266A Oral liquid for treating white scour of chicken and preparation method thereof |
08/17/2011 | CN102151265A Lansoprazole composition for injection |
08/17/2011 | CN102151264A Omeprazole sodium composition for injection |